CXCL2 and COVID-19: These included IL-6, TNF-α, CCL5, and CXCL2 with expression levels significantly surpassing those observed in SARS-CoV-2 and HKU4 controls (Figure 2D), which were positively related to severity in COVID-19 patients.20